Sarissa Capital Management as of Dec. 31, 2025
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 9 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Innoviva (INVA) | 25.3 | $56M | 2.8M | 19.99 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 24.1 | $54M | 16M | 3.37 | |
| Neurocrine Biosciences (NBIX) | 19.3 | $43M | 303k | 141.83 | |
| Cytokinetics Com New (CYTK) | 11.3 | $25M | 396k | 63.54 | |
| Amarin Corp Sponsored Adr (AMRN) | 10.5 | $23M | 1.7M | 13.96 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 5.4 | $12M | 182k | 66.55 | |
| Biohaven (BHVN) | 2.6 | $5.8M | 513k | 11.29 | |
| Regeneron Pharmaceuticals (REGN) | 1.5 | $3.2M | 4.2k | 771.87 | |
| Vor Biopharma Com New (VOR) | 0.1 | $332k | 25k | 13.08 |
